EA2183
OPEN TO ACCRUAL
Ph III Consolidative XRT in Pts w/ Oligometastatic HER2- Esophageal and Gastric Adenocarcinoma
UW19029
OPEN TO ACCRUAL
P2- 5FU, oxaliplatin, nal-IRI & immunotherapy (+ trastuzumab for HER2+) for adv esophageal & gastric
EA2212
OPEN TO ACCRUAL
Randomized Ph2 Periop Atezo +/- Chemo in Resectable MSI-H/dMMR Gastric & GEJ Cancer
S2303
OPEN TO ACCRUAL
Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer
UW21023
OPEN TO ACCRUAL
Ph 1/2 Dose Esc of DF1001 in Pts with Adv Solid Tumors and Expansion in Selected Indications